Search Instructions:

* Filter the ENTIRE resource library: Choose a Subject OR a Type of Item at the bottom of the page from the buttons to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.

Browse Items (10 total)

  • Tags: Healthcare Worker Safety

DecontaminatingN95s_062920_esp.pdf
Creator: NETEC
Subject: Elementos en Español
Item Type: Guide
Date Last Updated: 2020-06-29
Description: UVGI* Decontamination Cycle for N95 Respirators in Spanish. UVGI = Irradiación Germicida Ultravioleta

Conservation strategies: This resource contains recommendations facilitating conservation of equipment and supplies during contingency (expected shortages) and crisis (known shortages) capacities and should not be applied as guidance when conventional capacities are available.(1)

WorkSmart_esp.pdf
Creator: NETEC
Subject: Elementos en Español
Item Type: Guide
Date Last Updated: 2020-07-17
Description: Spanish Language version of Work Smart! Understand negative pressure isolation. Reduce your exposure risk. Conserve PPE.Comprende el aislamiento de áreas con el uso de presión negativa. Reduzca su riesgo de exposición. Mantiene a su EPP.

document-esp.pdf
Creator: NETEC
Subject: Elementos en Español
Item Type: Guide
Date Last Updated: 2020-11-02
Description: This printable flyer is a Spanish language version of "Gaining Strength and Developing Resiliency."

hide_me.png
Creator: NETEC
Subject: Infection Control
Item Type: Video
Date Last Updated: 2020-08-27
Description: The use of exhalation valves with N95s can expose the people around you to a virus if you are an asympotamic or presymptomatic carrier.N95 respirators come in different brands and types. One of the key features is whether they have an exhalation…

Creator: WHO
Subject: Infection Control
Item Type: Guide
Date Last Updated: 2018-09-26
Description: *Ebola, Marburg and other hemorrhagic fevers that share similar human-to-human transmission characteristicsGuidance document. WHO Team Access to Assistive Technology and Medical Devices, Access to Medicines and Health Products, Health Product…

hide_me.png
Creator: NETEC
Subject: Infection Control
Item Type: Guide
Date Last Updated: 2021-07-19
Description: NETEC recommends the “Identify, Isolate, and Inform” strategy. In this article, we provide a quick list of transmission precautions, PPE, waste, and other medical countermeasures.

Creator: Mumma JM, Howard-Anderson JR, Morgan JS, Schink K, Wheatley MJ, Kraft CS, Lane MA, Kaufman NH, Ayeni O, Brownsword EA, Jacob JT.
Subject: Infection Control
Item Type: Publication
Date Last Updated: 2021-09-10
Description: Understanding the cognitive determinants of healthcare worker (HCW) behavior is important for improving the use of infection prevention and control (IPC) practices. Given a patient requiring only standard precautions, we examined the dimensions along…

Creator: Tong, P. S., A. S. Kale, K. Ng, A. P. Loke, M. A. Choolani, C. L. Lim, Y. H. Chan, Y. S. Chong, P. A. Tambyah, and E. L. Yong.
Subject: Personnel Management
Item Type: Publication
Date Last Updated: 2015-11-16
Description: Outbreaks of emerging infectious diseases have led to guidelines recommending the routine use of N95 respirators for healthcare workers, many of whom are women of childbearing age. The respiratory effects of prolonged respirator use on pregnant women…

default_publication_icon.png
Creator: Benenson, Shmuel, Yonatan Oster, Matan J. Cohen, and Ran Nir-Paz.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-23
Description: The surge of coronavirus disease 2019 (Covid-19) around the world and the need for urgent and intensive medical care have weighed heavily on health care systems and hospitals.

default_publication_icon.png
Creator: Keehner, Jocelyn, Lucy E. Horton, Michael A. Pfeffer, Christopher A. Longhurst, Robert T. Schooley, Judith S. Currier, Shira R. Abeles, and Francesca J. Torriani.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-23
Description: Data from phase 3 clinical trials of messenger RNA (mRNA) vaccines through November 2020 showed 94.1% efficacy for the prevention of symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at 14 days after the second dose…